Continuing Pharmacy Education / CE Master List / Right Fit, Tight Seal: Building Better Cancer Care -RECORDED WEBINAR
Please use this button to register in our system as a new user, or to purchase a CE Activity.
For free CE's, returning users can simply click the "TAKE TEST/EVALUATION" button on the right.
Please use this button when you have completed the CE Activity and are ready to take the quiz and complete the evaluation.

Right Fit, Tight Seal: Building Better Cancer Care -RECORDED WEBINAR

About this Course

This course is a recorded (home study version) of the Arthur E. Schwarting Symposium on April 17, 2026 . The theme was "Measure Twice, Cut Once: A Carpentry Approach to Pharmacy."

 

Learning Objectives

Upon completion of this application based CE Activity, a pharmacist will be able to:

  • Recognize ways that general education and consultation contribute to better care
  • Identify crucial elements of a patient’s non-clinical care for patients with cancer
  • Demonstrate different ways to help patients at each phase of care

Release and Expiration Dates

Released:  April 17, 2026
Expires:  April 17, 2029

Course Fee

$17 Pharmacist

ACPE UAN

0009-0000-26-012-H01-P

Session Code

26RS12-AQU13

Accreditation Hours

1 hour of CE (0.1 CEUs)

Additional Information

 

How to Complete Evaluation:  When you are ready to submit posttest answers, go to the BLUE take test/evaluation button. Use the session code from your confirmation email or from the box above, not from the end of the video!

Accreditation Statement

The University of Connecticut School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Pharmacists and Pharmacy Technicians are eligible to participate in this knowledge-based activity and will receive up to 1 CE Hours (or 0.1 CEUs)  for completing the activity ACPE UAN 0009-0000-26-012-H01-P, passing the quiz with a grade of 70% or better, and completing an online evaluation. Statements of credit are available via the CPE Monitor online system and your participation will be recorded with CPE Monitor within 72 hours of submission.

Grant Funding

There is no grant funding for this activity.

Faculty

Thomas M. Levay, PharmD, CSP

Specialty Clinical Pharmacist II

Yale New Haven Health

Hamden, CT

Faculty Disclosure

In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy and Pharmaceutical Sciences requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.

  • Thomas Levay has no relationships with ineligible companies

Disclaimer

The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy and Pharmaceutical Sciences or its co-sponsor affiliates. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.

CONTENT

Posttest

Right Fit, Tight Seal: Building Better Cancer Care

26-012 P Home study

Posttest Questions

 

  1. Cancer patients are often met with varying degrees of fear and stigma which can negatively impact their outcomes. Which of the following is the best method to mitigate these concerns?
    1. Affirming that cancer is a medical condition rather than the consequence of poor personal choices
    2. Encouraging patients to hold questions and concerns until you complete all aspects of medication counseling
    3. Requesting that family and friends remain out of these counseling discussions as to not violate HIPPA

 

  1. Patients and healthcare professionals alike often encounter overlapping barriers in their pursuit of obtaining and providing quality care. What are some common barriers?
    1. Treatment complexity, adherence and tolerability, cost and accessibility
    2. Workplace burnout, annual salary, insurance approvals
    3. Image and self-worth, fear and misconception, treatment burden

 

  1. The current lifetime probability of developing any cancer in the United States is one in three people. Which age group is most commonly affected?
    1. Children and adults 0 to 30 years of age
    2. Adults 30 to 49 years of age
    3. Those 50 years of age and older

 

  1. Which of the following barriers to care do both patients and providers share as concerns?
    1. Managing adverse events and assessing their impact on quality of life
    2. Alleviating patient fears with education and defining goals of therapy
    3. Navigating drug-drug interactions with complex treatment regimens

 

  1. A large population of the United States remains uninsured or underinsured. What options are available for these populations to help patients afford treatment?
    1. 340b programs, grants, free drug programs
    2. 340b programs, Mark Cuban Cost Plus Drug, free drug programs
    3. Manufacturer copay cards, discount cards, Medicare payment plan (M3P)

 

  1. A Medicare patient has a high copay for his oncology drugs. He calls Medicare and asks if he can use an American Cancer Society grant, a free drug program, or a Manufacturer Copay Card. Which programs does the Medicare representative say are OK to use?
    1. An American Cancer Society grant, a Free Drug Program
    2. A Free Drug Program, a Manufacturer Copay Card
    3. A Manufacturer Copay Card, an American Cancer Society grant

VIDEO